top of page

Publications

Peer Reviewed 

Large-scale integration of omics and electronic health records to identify potential risk protein biomarkers and therapeutic drugs for cancer prevention.

Li Q, Song Q, Chen Z, Choi J, Moreno V, Ping J, Wen W, Li C, Shu X, Yan J, Shu XO, Cai Q, Long J, Huyghe JR, Pai R, Gruber SB, Yang Y, Casey G, Wang X, Toriola AT, Li L, Singh B, Lau KS, Zhou L, Zhang Z, Wu C, Peters U, Zheng W, Long Q, Yin Z, Guo X.

Am J Hum Genet. 2025 Dec 2:S0002-9297(25)00433-1. Online ahead of print.

PMID: 41338217

 

Pan-cancer analyses reveal disparities in tumor genomic profiles by race/ethnicity, age, and sex.

​Wen W, Choi J, Singh B, Li L, Toriola AT, Ciombor KK, Park BH, Shu X, Idrees K, Zheng W, Guo X. 

Cancer Epidemiology, Biomarkers & Prevention. 2025 Dec 1;34(12):2208-2218. Online ahead of print.

PMID: 40996301

A high-throughput 3D screen identifies drugs that induce epithelial polarity and enhance responsiveness to chemotherapy in colorectal cancer.

Harmych SJ, Hasaka TP, Sievers CK, Kang SW, Jones VT, Zhao Z, Kovtun O, Wahoski CC, Lau KS, Coffey RJ, Bauer JA, Singh B*.

Communications Biology. 2025 Aug 22;8(1):1261. *Corresponding author

PMID: 40847193

Metabolic response to small molecule therapy in colorectal cancer tracked with Raman spectroscopy and metabolomics.

Cutshaw GP, Joshi N, Wen X, Quam E, Hassan N, Bogatcheva G, Uthaman S, Waite J, Sarkar S, Singh B*, Bardhan R*.

Angewandte Chemie International Edition. 2024 Oct 21;63(43):e202410919. *Co-corresponding author

PMID: 38995663

 

Large-scale integration of omics and electronic health records to identify potential risk protein biomarkers and therapeutic drugs for cancer prevention and intervention.

Li Q, Song Q, Chen Z, Choi J, Moreno V, Ping J, Wen W, Li C, Shu X, Yan J, Shu XO, Cai Q, Long J, Huyghe JR, Pai R, Gruber SB, Casey G, Wang X, Toriola AT, Li L, Singh B, Lau KS, Zhou L, Wu C, Peters U, Zheng W, Long Q, Yin Z, Guo X.

medRxiv [Preprint]. 2024 May 31:2024.05.29.24308170.

PMID: 38853880

Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer.

Jones VT, Graves-Deal R, Cao Z, Bogatcheva G, Ramirez MA, Harmych SJ, Higginbotham JN, Sharma V, Damalanka VC, Wahoski C, Joshi N, Roland JT, Ayers GD, Liu Q, Coffey RJ, Janetka JW, Singh B*

Cellular and Molecular Life Sciences. 2024;81(1):28. *Corresponding author

PMID: 38212428

Monitoring Metabolic Changes in Response to Chemotherapies in Cancer with Raman Spectroscopy and Metabolomics.

Cutshaw G, Hassan N, Uthaman S, Wen X, Singh B, Sarkar A, Bardhan R.

Analytical Chemistry. 2023;95(35):13172-13184.

PMID: 37605298

A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer.

Cao T, Lu Y, Wang Q, Qin H, Li H, Guo H, Ge M, Glass SE, Singh B, Zhang W, Dong J, Du F, Qian A, Tian Y, Wang X, Li C, Wu K, Fan D, Nie Y, Coffey RJ, Zhao X.

​Journal of Clinical Investigation. 2022;132(6):e154074.

PMID: 35289315

Induction of apically mistrafficked EREG disrupts epithelial polarity via aberrant EGFR signaling.

Singh B, Bogatcheva G, Krystofiak E, McKinley ET, Hill S, Rose KL, Higginbotham JN, Coffey RJ. 

Journal of Cell Science. 134(18):jcs255927, 2021. 

PMID: 34406412

*Accompanied by “First Person” interview for first author in Journal of Cell Science 

*Highlighted in the American Cancer Society’s Podcast Theory Lab

Cell surface integrin a5 clustering negatively regulates receptor tyrosine kinase signaling in colorectal cancer cells via glycogen synthase kinase 3.

Starchenko A, Graves-Deal R, Brubaker D, Li C, Yang Y, Singh B, Coffey RJ, Lauffeburger DA.

Integrative Biology. 13:153-166, 2021.

PMID: 34037774

Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry.

Wen X, Ou Y-C, Bogatcheva G, Thomas G, Mahadevan-Jansen A, Singh B, Lin EC, Bardhan R.

Chemical Science. 11:9863-9874, 2020.

PMID: 34094246

 

Protein kinase A-mediated phosphorylation of naked cuticle homolog 2 stimulates cell-surface delivery of transforming growth factor-α for epidermal growth factor receptor transactivation.

Cao Z*, Singh B*, Li C, Markham NO, Carrington LJ, Franklin JL, Graves-Deal R, Kennedy EJ, Goldenring JR, Coffey RJ.

Traffic. 20:357-368, 2019. *Co-first author

PMID: 30941853

Broad-spectrum receptor tyrosine kinase inhibitors overcome de novo and acquired modes of resistance to EGFR-targeted therapies in colorectal cancer.

Graves-Deal R, Bogatcheva G, Rehman S, Lu Y, Higginbotham JN, Singh B*

Oncotarget. 10:1320-1333, 2019. *Corresponding author

PMID: 30863492

lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling.

Lu Y, Zhao Z, Liu Q, Li C, Graves-Deal R, Cao Z, Singh B, Franklin JL, Wang J, Hu H, Yang M, Yeatman TJ, Lee E, Saito-Diaz K, Hinger S, Patton JG, Chung CH, Emmrich S, Klusmann J-H, Fan D, Coffey RJ.

Nature Medicine. 23:1331-1341, 2017.

PMID: 29035371

Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer.

Li C*, Singh B*, Graves-Deal R, Ma H, Starchenko A, Fry WH, Lu Y, Wang Y, Khan MP, Milne GL, Zhao S, Ayers GD, Washington MK, Yeatman TJ, McDonald OG, Liu Q, and Coffey RJ.

Proceedings of the National Academy of Sciences of the USA (PNAS). 114:E2852-E2861, 2017. *Co-first author

PMID: 28320945

Clustering of integrin alpha 5 at the lateral membrane restores epithelial polarity in invasive colorectal cancer cells.

Starchenko A, Graves-Deal R, Yang YP, Li C, Zent R, Singh B, and Coffey RJ.

Molecular Biology of the Cell. 28:1288-1300, 2017.

PMID: 28356422

Induction of lateral lumens through disruption of a monoleucine-based basolateral-sorting motif in betacellulin.

Singh B*, Bogatcheva G, Starchenko A, Sinnaeve J, Lapierre LA, Williams JA, Goldenring JR, and Coffey RJ.

Journal of Cell Science. 128:3444-3455, 2015. *Corresponding author

PMID: 26272915

*Highlighted in Journal of Cell Science “In this issue”, and recommended by Faculty of 1000 

 

Transformation of polarized epithelial cells by apical mistrafficking of epiregulin.

Singh B, Bogatcheva G, Washington MK, and Coffey RJ.

Proceedings of the National Academy of Sciences of the USA (PNAS). 110:8960-8965, 2013.

PMID: 23671122

Identification of a novel mono-leucine basolateral sorting motif within the cytoplasmic domain of amphiregulin.

Gephart JD, Singh B, Higginbotham JN, Franklin JL, Gonzales A, Folsch H, and Coffey RJ.

Traffic. 12:1793-1804, 2011.

PMID: 21917092

UV-induced EGFR signal transactivation is dependent on proligand shedding by activated metalloproteases in skin cancer cell lines.

Singh B, Schneider M, Knyazev P, and Ullrich A. 

International Journal of Cancer. 124:531-9, 2009.

PMID: 19003995

Phosphoprotein phosphatase of Mycobacterium tuberculosis dephosphorylates serine-threonine kinases PknA and PknB.

Chopra P, Singh B, Singh R, Vohra R, Koul A, Meena LS, Koduri H, Ghildiyal M, Deol P, Das TK, Tyagi AK, and Singh Y. 

Biochemical and Biophysical Research Communications. 311:112-20, 2003.

PMID: 14575702

Review Articles

Energetic mapping of EGFR binding hotspots to drive design of new anti-EGFR biologics. 

Tydings CW, Singh B, Smith AW, Ledwich KV, Lovly CM, Walker AS, Meiler J, Brown BP.

Protein Science. 2024;33(10):e5141.

PMID: 39275996

The Roles of RAC1 and RAC1B in colorectal cancer and potential contribution to cetuximab resistance. 

Wahoski C, Singh B*.

Cancers (Basel). 2024 Jul 6;16(13):2472. *Corresponding author

PMID: 39001533

Sequence and structural insights of monoleucine-based sorting motifs contained within the cytoplasmic domains of basolateral proteins. 

Harmych SJ, Tydings CW, Meiler J, Singh B*.

Frontiers in Cell and Developmental Biology. 2024;12:1379224. *Corresponding author

PMID: 38495621

The Room Where It Happens: Addressing Diversity, Equity, and Inclusion in NCTN Clinical Trial Leadership. 

Snyder RA, Burtness B, Delrivero J, Doroshow D, Hitchcock K, Kalyan A, Kim CA, Lukovic J, Chao M, Namrata V, Parikh A, Sanford N, Singh B, Shen C, Shroff R, Goodman K, Kunz, P.

Journal of the National Cancer Institute. 2023;115(10):1132-1138.

PMID: 37364007​​

EGF receptor ligands: recent advances

Singh B, Carpenter G, and Coffey RJ.

F1000Research pii: F1000 Faculty Rev-2270, 2016.

PMID: 27635238

From wavy hair to naked proteins: The role of transforming growth factor alpha in health and disease.

Singh B and Coffey RJ.

Seminars in Cell and Developmental Biology 28:12-21, 2014. Review.

PMID: 24631356

Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Singh B and Coffey RJ.

Annual Review of Physiology 76:275-300, 2014. Review.

PMID: 24215440

Science Outreach

Characterization of the downstream effects of apical mistrafficking of epiregulin and potential for transformation in polarized epithelial cells.

Rehman S, Bogatcheva G, Coffey RJ, and Singh B. 

Vanderbilt science outreach journal: Young Scientist 6:33-36, 2016.

Article Link

bottom of page